Health state utility values in patients undergoing endoscopic sinus surgery
- PMID: 22034223
- PMCID: PMC3232034
- DOI: 10.1002/lary.21847
Health state utility values in patients undergoing endoscopic sinus surgery
Abstract
Objectives/hypothesis: The primary study goal was to measure health state utility values in patients with chronic rhinosinusitis (CRS) before and after undergoing endoscopic sinus surgery (ESS). A secondary goal was to assess the meaning of these values by comparing them with other chronic disease processes and currently available medical or surgical treatments.
Study design: Prospective, observational cohort study.
Methods: Adults with CRS were enrolled after electing ESS and were observed for a 5-year period. Baseline demographic and medical comorbidities were recorded for each patient, as well as findings from computed tomography (CT), endoscopy, olfaction, and disease-specific quality of life scores. Utility values were derived using the Short-Form 6D (SF-6D) at baseline and again after surgery.
Results: The mean SF-6D utility value for the baseline health state of all patients with CRS (n = 232) was 0.65 (95% confidence interval [CI]: 0.63-0.66). Baseline utility values correlated with disease-specific quality of life as measured by the Rhinosinusitis Disability Index (r = -0.660; P < .001), but not baseline CT, endoscopy, or olfactory scores. Follow-up utility values (≥ 6 months) after ESS improved by 0.087 (95% CI: 0.06-0.12; P < .001) in patients with no history of sinus surgery and 0.062 (95% CI: 0.04-0.09; P < .001) in those undergoing a revision procedure.
Conclusions: Patients with CRS who failed medical therapy and elected to undergo ESS reported health state utility values that were significantly lower than the US population norm. Utility values showed improvement after ESS, which was statistically and clinically significant. These results provide the initial data necessary for formal cost-effectiveness analyses incorporating ESS.
Trial registration: ClinicalTrials.gov NCT00799097.
Copyright © 2011 The American Laryngological, Rhinological, and Otological Society, Inc.
Conflict of interest statement
Figures
Similar articles
-
Concurrent septoplasty during endoscopic sinus surgery for chronic rhinosinusitis: does it confound outcomes assessment?Laryngoscope. 2011 Dec;121(12):2679-83. doi: 10.1002/lary.22361. Epub 2011 Oct 27. Laryngoscope. 2011. PMID: 22034233 Free PMC article.
-
Long-term utility outcomes in patients undergoing endoscopic sinus surgery.Laryngoscope. 2014 Jan;124(1):19-23. doi: 10.1002/lary.24135. Epub 2013 May 13. Laryngoscope. 2014. PMID: 23670699 Free PMC article. Clinical Trial.
-
Health utility outcomes in patients undergoing medical management for chronic rhinosinusitis: a prospective multiinstitutional study.Int Forum Allergy Rhinol. 2015 Nov;5(11):1018-27. doi: 10.1002/alr.21588. Epub 2015 Jul 3. Int Forum Allergy Rhinol. 2015. PMID: 26140502 Free PMC article. Clinical Trial.
-
Symptom outcomes following endoscopic sinus surgery.Curr Opin Otolaryngol Head Neck Surg. 2009 Feb;17(1):50-8. doi: 10.1097/MOO.0b013e32831b9e2a. Curr Opin Otolaryngol Head Neck Surg. 2009. PMID: 19225306 Review.
-
Surgical therapy vs continued medical therapy for medically refractory chronic rhinosinusitis: a systematic review and meta-analysis.Int Forum Allergy Rhinol. 2017 Feb;7(2):119-127. doi: 10.1002/alr.21872. Epub 2016 Nov 11. Int Forum Allergy Rhinol. 2017. PMID: 27863163 Review.
Cited by
-
The value of biomarkers in the therapy of CRSwNP with biologicals-a long-term follow-up of dupilumab therapy.Eur Arch Otorhinolaryngol. 2024 May 6. doi: 10.1007/s00405-024-08574-4. Online ahead of print. Eur Arch Otorhinolaryngol. 2024. PMID: 38709320
-
[Decision-making in the treatment of chronic rhinosinusitis with nasal polyps in the era of biologics].HNO. 2024 Apr;72(4):225-230. doi: 10.1007/s00106-024-01430-1. Epub 2024 Feb 20. HNO. 2024. PMID: 38376799 Review. German.
-
Particulate matter exposure is associated with increased inflammatory cytokines and eosinophils in chronic rhinosinusitis.Allergy. 2024 May;79(5):1219-1229. doi: 10.1111/all.16006. Epub 2024 Jan 5. Allergy. 2024. PMID: 38180309
-
Biologic Therapies in Chronic Rhinosinusitis with Nasal Polyposis: Overview of Systematic Reviews and Updated Systematic Review.Indian J Otolaryngol Head Neck Surg. 2023 Apr;75(Suppl 1):650-660. doi: 10.1007/s12070-022-03144-8. Epub 2022 Oct 15. Indian J Otolaryngol Head Neck Surg. 2023. PMID: 37206723 Free PMC article.
-
Real-world burden and treatment of chronic rhinosinusitis in Japan: A retrospective claims database analysis.Laryngoscope Investig Otolaryngol. 2023 Mar 3;8(2):346-356. doi: 10.1002/lio2.1027. eCollection 2023 Apr. Laryngoscope Investig Otolaryngol. 2023. PMID: 37090876 Free PMC article.
References
-
- Torrance GW. Measurement of health state utilities for economic appraisal: A review. J Health Econom. 1986;5:1–30. - PubMed
-
- Ware JE, Kosinski M, Gandek BG, et al. The factor structure of the SF-36® health survey in 10 countries: Results from the International Quality of Life Assessment (IQOLA) project. J Clin Epidemiol. 1998;51(11):1159–1165. - PubMed
-
- Russell LB, Gold MR, Siegel JE, Daniels N, Weinstein MC. The role of cost-effectiveness analysis in health and medicine. Panel on Cost-Effectiveness in Health and Medicine. JAMA. 1996;276:1172–1177. - PubMed
Publication types
MeSH terms
Associated data
Grants and funding
LinkOut - more resources
Full Text Sources
Medical